1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Assa-Munt, N.
Jia, X.
Laakkonen, P.
Ruoslahti, E.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
40
2373
2378
10.1021/bi002101f
11327857
Solution structures and integrin binding activities of an RGD peptide with two isomers.
2001
US
ANNU.REV.CELL DEV.BIOL.
1081-0706
12
697
715
10.1146/annurev.cellbio.12.1.697
RGD and other recognition sequences for integrins.
1996
10.2210/pdb1fuv/pdb
pdb_00001fuv
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1150.311
RGD PEPTIDE ISOMER-A
1
syn
polymer
no
no
ACDCRGDCFCG
ACDCRGDCFCG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-05-16
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
1FUL is the solution structure of an RGD Peptide Isomer-B
RCSB
Y
RCSB
2000-09-15
REL
REL
peptide was chemically synthesized
sample
back calculated data agree with experimental NOESY spectrum,structures with acceptable covalent geometry,structures with favorable non-bond energy,structures with the least restraint violations,structures with the lowest energy
100
19
2D NOESY
DQF-COSY
1
atm
293
K
distance geometry simulated annealing
8
closest to the average
2.5 mg
DMSO
Alex.T. Brunger
refinement
X-PLOR
3.851
500
Varian
UNITYPLUS
ALA
1
n
1
ALA
1
A
CYS
2
n
2
CYS
2
A
ASP
3
n
3
ASP
3
A
CYS
4
n
4
CYS
4
A
ARG
5
n
5
ARG
5
A
GLY
6
n
6
GLY
6
A
ASP
7
n
7
ASP
7
A
CYS
8
n
8
CYS
8
A
PHE
9
n
9
PHE
9
A
CYS
10
n
10
CYS
10
A
GLY
11
n
11
GLY
11
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
O
O
ALA
PHE
1
9
2.15
1
A
ARG
5
0.307
SIDE CHAIN
2
A
ARG
5
0.275
SIDE CHAIN
3
A
ARG
5
0.315
SIDE CHAIN
4
A
ARG
5
0.233
SIDE CHAIN
5
A
ARG
5
0.314
SIDE CHAIN
6
A
ARG
5
0.250
SIDE CHAIN
7
A
ARG
5
0.315
SIDE CHAIN
8
A
ARG
5
0.264
SIDE CHAIN
9
A
ARG
5
0.296
SIDE CHAIN
10
A
ARG
5
0.288
SIDE CHAIN
11
A
ARG
5
0.278
SIDE CHAIN
12
A
ARG
5
0.300
SIDE CHAIN
13
A
ARG
5
0.266
SIDE CHAIN
14
A
ARG
5
0.266
SIDE CHAIN
15
A
ARG
5
0.277
SIDE CHAIN
16
A
ARG
5
0.318
SIDE CHAIN
17
A
ARG
5
0.297
SIDE CHAIN
18
A
ARG
5
0.308
SIDE CHAIN
19
A
ARG
5
0.246
SIDE CHAIN
1
A
ASP
3
-137.45
-57.32
1
A
CYS
4
-54.79
-116.02
1
A
ARG
5
-155.19
-47.25
1
A
CYS
8
-90.83
56.07
2
A
ASP
3
-136.70
-64.70
2
A
CYS
4
-55.52
-112.75
2
A
ARG
5
-152.99
-74.90
2
A
CYS
8
-99.71
32.17
2
A
PHE
9
-49.00
170.48
3
A
ASP
3
-128.08
-62.35
3
A
CYS
4
-54.64
-109.56
3
A
ARG
5
-153.51
-78.08
3
A
PHE
9
-46.61
172.65
4
A
CYS
4
-49.16
-106.47
4
A
ARG
5
-154.85
-87.70
4
A
ASP
7
-134.23
-50.72
4
A
PHE
9
-54.99
178.43
5
A
ASP
3
-133.17
-64.63
5
A
CYS
4
-52.76
-108.81
5
A
ARG
5
-152.75
-77.24
5
A
CYS
8
-90.47
49.50
6
A
ASP
3
-136.01
-62.61
6
A
CYS
4
-52.65
-115.14
6
A
ARG
5
-154.72
-45.36
6
A
CYS
8
-96.24
40.04
7
A
ASP
3
-134.51
-66.19
7
A
CYS
4
-50.61
-110.11
7
A
ARG
5
-153.55
-83.17
7
A
CYS
8
-85.76
41.75
8
A
ASP
3
-133.83
-62.90
8
A
CYS
4
-54.41
-112.84
8
A
ARG
5
-154.19
-89.60
8
A
ASP
7
-139.55
-49.79
8
A
CYS
8
-90.31
33.51
9
A
ASP
3
-136.16
-70.49
9
A
CYS
4
-49.93
-111.15
9
A
ARG
5
-153.37
-85.28
9
A
ASP
7
-121.50
-56.24
9
A
CYS
8
-82.84
37.32
10
A
ASP
3
-131.30
-63.41
10
A
CYS
4
-53.63
-110.73
10
A
ARG
5
-153.78
-85.26
10
A
ASP
7
-127.82
-52.29
10
A
CYS
8
-88.86
34.35
11
A
ASP
3
-126.36
-64.15
11
A
CYS
4
-51.51
-110.13
11
A
ARG
5
-153.72
-82.56
11
A
CYS
8
-90.21
32.15
12
A
ASP
3
-134.96
-65.60
12
A
CYS
4
-51.34
-111.15
12
A
ARG
5
-153.47
-77.90
12
A
CYS
8
-86.36
48.95
13
A
ASP
3
-137.22
-63.12
13
A
CYS
4
-57.61
-112.81
13
A
ARG
5
-152.93
-74.12
13
A
PHE
9
-43.98
168.86
14
A
ASP
3
-139.36
-48.46
14
A
CYS
4
-60.94
-120.67
14
A
ARG
5
-154.53
-80.59
14
A
ASP
7
-139.40
-71.62
15
A
ASP
3
-124.44
-61.11
15
A
CYS
4
-54.96
-107.45
15
A
ARG
5
-153.75
-76.83
15
A
PHE
9
-48.60
173.35
16
A
ASP
3
-131.99
-63.90
16
A
CYS
4
-52.59
-110.80
16
A
ARG
5
-153.54
-84.93
16
A
ASP
7
-122.93
-52.30
16
A
CYS
8
-88.41
33.81
17
A
ASP
3
-120.98
-60.62
17
A
CYS
4
-56.20
-106.90
17
A
ARG
5
-153.12
-74.31
17
A
PHE
9
-44.08
171.62
18
A
ASP
3
-125.92
-60.67
18
A
CYS
4
-55.21
-107.86
18
A
ARG
5
-153.55
-77.03
18
A
PHE
9
-47.10
174.39
18
A
CYS
10
-94.85
49.38
19
A
CYS
4
-55.39
-104.98
19
A
ARG
5
-153.92
-74.66
19
A
PHE
9
-47.60
174.48
SOLUTION STRUCTURE OF AN RGD PEPTIDE ISOMER-A
1
N
N
disulf
2.026
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
10
A
SG
CYS
10
1_555
disulf
2.023
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
8
A
SG
CYS
8
1_555
CELL ADHESION
Double S-S bonds, type I beta-turn, CELL ADHESION
1FUV
PDB
1
1FUV
1
11
1FUV
1
11
1FUV
A
1
1
11
1
P 1